Magnetic Nanomaterials Mediate Electromagnetic Stimulations of Nerves for Applications in Stem Cell and Cancer Treatments
Source abstract
Abstract
Although some progress has been made in the treatment of cancer, challenges remain. In recent years, advancements in nanotechnology and stem cell therapy have provided new approaches for use in regenerative medicine and cancer treatment. Among them, magnetic nanomaterials have attracted widespread attention in the field of regenerative medicine and cancer; this is because they have high levels of safety and low levels of invasibility, promote stem cell differentiation, and affect biological nerve signals. In contrast to pure magnetic stimulation, magnetic nanomaterials can act as amplifiers of an applied electromagnetic field in vivo, and by generating different effects (thermal, electrical, magnetic, mechanical, etc.), the corresponding ion channels are activated, thus enabling the modulation of neuronal activity with higher levels of precision and local modulation. In this review, first, we focused on the relationship between biological nerve signals and stem cell differentiation, and tumor development. In addition, the effects of magnetic nanomaterials on biological neural signals and the tumor environment were discussed. Finally, we introduced the application of magnetic-nanomaterial-mediated electromagnetic stimulation in regenerative medicine and its potential in the field of cancer therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Neuroscience and Neural Engineering · Planarian Biology and Electrostimulation · Photoreceptor and optogenetics research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China
Funding
National Key Projects for Research and Development Program of China
References (100+)
Show source-provided references
1. Cancer nanomedicine: Progress, challenges and opportunities10.1038/nrc.2016.108 ↗
2. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery10.2174/1568009618666180628160211 ↗
3. Nanotechnology in cancer diagnosis: Progress, challenges and opportunities10.1186/s13045-019-0833-3 ↗
4. Imaging hypoxia to improve radiotherapy outcome10.1038/nrclinonc.2012.171 ↗
5. Advances in the systemic treatment of triple-negative breast cancer10.3747/co.25.3954 ↗
6. Can advanced-stage ovarian cancer be cured?10.1038/nrclinonc.2015.224 ↗
7. Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?10.3389/fphar.2018.00245 ↗
8. Opportunities and challenges of radiotherapy for treating cancer10.1038/nrclinonc.2015.120 ↗
9. Global cancer surgery: Delivering safe, aff ordable, and timely cancer surgery10.1016/S1470-2045(15)00223-5 ↗
10. Application progress of nanotechnology in regenerative medicine of diabetes mellitus10.1016/j.diabres.2022.109966 ↗
11. Regenerative medicine technologies applied to transplant medicine. An update10.3389/fbioe.2022.1015628 ↗
12. From Cells to Organs: The Present and Future of Regenerative Medicine10.1007/5584_2021_657 ↗
13. Regenerative medicine: Current therapies and future directions10.1073/pnas.1508520112 ↗
14. Regenerative medicine. Opportunities and challenges: A brief overview10.1098/rsif.2010.0362.focus ↗
15. Chitosan as an environment friendly biomaterial—A review on recent modifications and applications10.1016/j.ijbiomac.2019.10.113 ↗
16. Biocompatible Iron Oxide Nanoring-Labeled Mesenchymal Stem Cells: An Innovative Magnetothermal Approach for Cell Tracking and Targeted Stroke Therapy10.1021/acsnano.2c07581 ↗
17. Magnetic nanocomposites for biomedical applications10.1016/j.cis.2022.102771 ↗
18. Furlani, F., Rossi, A., Grimaudo, M.A., Bassi, G., Giusto, E., Molinari, F., Lista, F., Montesi, M., and Panseri, S. (2022). Controlled Liposome Delivery from Chitosan-Based Thermosensitive Hydrogel for Regenerative Medicine. Int. J. Mol. Sci., 23.10.3390/ijms23020894 ↗
19. Phosphatidylserine liposome multilayers mediate the M1-to-M2 macrophage polarization to enhance bone tissue regeneration10.1016/j.actbio.2022.10.024 ↗
20. Shyngys, M., Ren, J., Liang, X., Miao, J., Blocki, A., and Beyer, S. (2021). Metal-Organic Framework (MOF)-Based Biomaterials for Tissue Engineering and Regenerative Medicine. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.603608 ↗
21. Accelerated Bone Regeneration by MOF Modified Multifunctional Membranes through Enhancement of Osteogenic and Angiogenic Performance10.1002/adhm.202001369 ↗
22. Adaptive iron-based magnetic nanomaterials of high performance for biomedical applications10.1007/s12274-021-3546-1 ↗
23. Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy10.1177/20406207211018042 ↗
24. Recent Advances of Magnetic Nanomaterials for Bioimaging, Drug Delivery, and Cell Therapy10.1021/acsanm.2c02014 ↗
25. Coupling of mechanical deformation and electromagnetic fields in biological cells10.1103/RevModPhys.94.025003 ↗
26. Links between extremely high frequency electromagnetic waves and their biological manifestations10.2298/ABS140228049A ↗
27. Biomedical applications of terahertz technology10.1088/0022-3727/39/17/R01 ↗
28. Extremely low frequency (ELF) pulsed-gradient magnetic fields inhibit malignant tumour growth at different biological levels10.1006/cbir.2002.0883 ↗
29. Microsecond and nanosecond electric pulses in cancer treatments10.1002/bem.20692 ↗
30. Nanosecond pulsed electric fields modulate cell function through intracellular signal transduction mechanisms10.1088/0967-3334/25/4/023 ↗
31. An introduction to the basic principles of magnetic nerve stimulation10.1097/00004691-199101000-00005 ↗
32. Neurostimulation in Alzheimer’s disease: From basic research to clinical applications10.1007/s10072-015-2120-6 ↗
33. Review of Neuromodulation Techniques and Technological Limitations10.1080/02564602.2015.1106926 ↗
34. Transcranial magnetic stimulation in the treatment of psychiatric disorders10.1007/s11920-009-0068-z ↗
35. Brain Neuromodulation Techniques: A Review10.1177/1073858416646707 ↗
36. A framework for targeting alternative brain regions with repetitive transcranial magnetic stimulation in the treatment of depression
37. Recent Progress in Engineering Mesenchymal Stem Cell Differentiation10.1007/s12015-020-09979-4 ↗
38. Mesenchymal Stem Cell-Mediated Autophagy Inhibition10.1161/CIRCRESAHA.118.313592 ↗
39. Enteric Nervous System Regulation of Intestinal Stem Cell Differentiation and Epithelial Monolayer Function10.1038/s41598-018-24768-3 ↗
40. Inhibition of IKK/NF-kappaB Signaling Enhances Differentiation of Mesenchymal Stromal Cells from Human Embryonic Stem Cells10.1016/j.stemcr.2016.02.006 ↗
41. Sensory nerves regulate mesenchymal stromal cell lineage commitment by tuning sympathetic tones10.1172/JCI131554 ↗
42. The neural system regulates bone homeostasis via mesenchymal stem cells: A translational approach10.7150/thno.43771 ↗
43. Black-Phosphorus-Incorporated Hydrogel as a Conductive and Biodegradable Platform for Enhancement of the Neural Differentiation of Mesenchymal Stem Cells10.1002/adfm.202000177 ↗
44. Self-Powered Electrical Stimulation for Enhancing Neural Differentiation of Mesenchymal Stem Cells on Graphene-Poly(3,4-ethylenedioxythiophene) Hybrid Microfibers10.1021/acsnano.6b00200 ↗
45. The neurotransmitter receptor Gabbr1 regulates proliferation and function of hematopoietic stem and progenitor cells10.1182/blood.2019004415 ↗
46. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
47. Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR/ERK1/2 signaling pathway10.3892/ijo.2015.2939 ↗
48. Tumour-induced neoneurogenesis and perineural tumour growth: A mathematical approach10.1038/srep20684 ↗
49. Nervous system and primary liver cancer10.1016/j.bbcan.2018.04.002 ↗
50. Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization10.1002/hep.24079 ↗
51. Acetylcholinesterase is associated with a decrease in cell proliferation of hepatocellular carcinoma cells10.1016/j.bbadis.2015.04.003 ↗
52. Nie, H., Cao, Q., Zhu, L., Gong, Y., Gu, J., and He, Z. (2013). Acetylcholine acts on androgen receptor to promote the migration and invasion but inhibit the apoptosis of human hepatocarcinoma. PLoS ONE, 8.10.1371/journal.pone.0061678 ↗
53. Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells10.1016/j.bbi.2016.08.016 ↗
54. Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: With reference to nervous system10.1038/onc.2015.484 ↗
55. Environmental eustress modulates beta-ARs/CCL2 axis to induce anti-tumor immunity and sensitize immunotherapy against liver cancer in mice10.1038/s41467-021-25967-9 ↗
56. Hu, J., Chen, W., Shen, L., Chen, Z., and Huang, J. (2022). Crosstalk between the peripheral nervous system and breast cancer influences tumor progression. Biochim. Biophys. Acta Rev. Cancer, 1877.10.1016/j.bbcan.2022.188828 ↗
57. Synaptic proximity enables NMDAR signalling to promote brain metastasis10.1038/s41586-019-1576-6 ↗
58. Dangerous liaisons as tumour cells form synapses with neurons10.1038/d41586-019-02746-7 ↗
59. Therapeutic avenues for cancer neuroscience: Translational frontiers and clinical opportunities10.1016/S1470-2045(21)00596-9 ↗
60. The Sympathetic Nervous System Drives Tumor Angiogenesis10.1016/j.trecan.2017.11.008 ↗
61. Role of the parasympathetic nervous system in cancer initiation and progression10.1007/s12094-020-02465-w ↗
62. Serum serotonin as unexpected potential marker for staging of experimental hepatocellular carcinoma10.1016/j.biopha.2016.07.005 ↗
63. Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma10.1002/ijc.24909 ↗
64. Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma10.3748/wjg.v20.i14.4076 ↗
65. RNA binding protein Nova1 promotes tumor growth in vivo and its potential mechanism as an oncogene may due to its interaction with GABAA Receptor-gamma210.1186/s12929-016-0288-6 ↗
66. Progenitors from the central nervous system drive neurogenesis in cancer10.1038/s41586-019-1219-y ↗
67. Autonomic nerve development contributes to prostate cancer progression
68. Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer10.1016/j.cell.2020.10.016 ↗
69. Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness10.1158/2159-8290.CD-18-0046 ↗
70. Jack of many trades: Multifaceted role of neuropilins in pancreatic cancer10.1002/cam4.1715 ↗
71. The Serotonin Neurotransmitter Modulates Virulence of Enteric Pathogens10.1016/j.chom.2020.05.004 ↗
72. Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer10.1186/s12943-020-01251-0 ↗
73. Leucine-rich repeat neuronal protein-1 suppresses apoptosis of gastric cancer cells through regulation of Fas/FasL10.1111/cas.14042 ↗
74. Selective inductive heating of lymph nodes10.1097/00000658-195710000-00007 ↗
75. Dynamically Reversible Iron Oxide Nanoparticle Assemblies for Targeted Amplification of T1-Weighted Magnetic Resonance Imaging of Tumors10.1021/acs.nanolett.8b04411 ↗
76. Highly Sensitive Diagnosis of Small Hepatocellular Carcinoma Using pH-Responsive Iron Oxide Nanocluster Assemblies10.1021/jacs.8b04169 ↗
77. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer10.1056/NEJMoa022749 ↗
78. Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy10.1109/TMAG.2010.2046907 ↗
79. Safety of ferumoxytol in patients with anemia and CKD10.1053/j.ajkd.2008.08.001 ↗
80. The tumor immune-microenvironment in gastric cancer10.1177/03008916211070051 ↗
81. A sinfully easy way to interpret ABGs
82. Immunosuppressive strategies that are mediated by tumor cells10.1146/annurev.immunol.25.022106.141609 ↗
83. Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts Activation10.1021/acs.nanolett.7b05284 ↗
84. Magneto-Activation and Magnetic Resonance Imaging of Natural Killer Cells Labeled with Magnetic Nanocomplexes for the Treatment of Solid Tumors10.1021/acsnano.1c01889 ↗
85. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues10.1038/nnano.2016.168 ↗
86. A review on the impacts of nanomaterials on neuromodulation and neurological dysfunction using a zebrafish animal model10.1016/j.cbpc.2022.109428 ↗
87. Biointegrated and Wirelessly Powered Implantable Brain Devices: A Review10.1109/TBCAS.2020.2966920 ↗
88. An atlas of nano-enabled neural interfaces10.1038/s41565-019-0487-x ↗
89. Remote control of ion channels and neurons through magnetic-field heating of nanoparticles10.1038/nnano.2010.125 ↗
90. Non-contact long-range magnetic stimulation of mechanosensitive ion channels in freely moving animals10.1038/s41563-020-00896-y ↗
91. Magnetoelectric ‘spin’ on stimulating the brain10.2217/nnm.15.52 ↗
92. In Vivo Wireless Brain Stimulation via Non-invasive and Targeted Delivery of Magnetoelectric Nanoparticles10.1007/s13311-021-01071-0 ↗
93. International Commission on Non-Ionizing Radiation Protection (2010). Guidelines for limiting exposure to time-varying electric and magnetic fields (1 Hz to 100 kHz). Health Phys., 99, 818–836.10.1097/HP.0b013e3181f06c86 ↗
94. Electrospinning Multilayered Scaffolds Loaded with Melatonin and Fe3O4 Magnetic Nanoparticles for Peripheral Nerve Regeneration10.1002/adfm.202004537 ↗
95. The Story of Nanoparticles in Differentiation of Stem Cells into Neural Cells10.1007/s11064-019-02900-7 ↗
96. When nano meets stem: The impact of nanotechnology in stem cell biology10.1016/j.jbiosc.2011.08.024 ↗
97. Magnetic nanoparticles as potential candidates for biomedical and biological applications
98. Stem cells: Their source, potency and use in regenerative therapies with focus on adipose-derived stem cells—A review10.1016/j.biotechadv.2018.03.011 ↗
99. The Collection of Adipose Derived Stem Cells using Water-Jet Assisted Lipoplasty for their Use in Plastic and Reconstructive Surgery: A Preliminary Study10.3389/fcell.2016.00136 ↗
100. Emerging Strategies for Stem Cell Lineage Commitment in Tissue Engineering and Regenerative Medicine10.1021/acsbiomaterials.8b00532 ↗